← Leaderboards
Nabeel Hamzeh
National Jewish Health
$3,068,174
Attributed
$8,149,967
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2015–21$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,149,967 · 5
By mechanism
R01$7,704,092 · 3
R21$435,875 · 1
R13$10,000 · 1
Top collaborators
- Brian P O'Connor14 shared
- Laura L Koth4 shared
- Sonia Leach4 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Lisa A Maier$11,952,941
- Sonia Leach$1,607,855
- Hong-Bing Shu$2,685,012
- Ivana V Yang$13,155,768
- Nancy Weijiun Lin$621,533
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungSarcoidosisEtiologySamplingGene Expression ProfileAffectProductionPrevalenceGenomicsGene ExpressionPatternData SetMolecularPathway InteractionsPublic Health RelevanceGenesCellsGenome-WideDiagnosisGenetic TranscriptionTranscriptome SequencingPathogenesisTranscriptomeGranulomatous
Grant awards (15)
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis$992,527
R01 · FY2021 · HL
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis$999,912
R01 · FY2020 · HL
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis$1,004,873
R01 · FY2019 · HL
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis$414,793
R01 · FY2019 · HL
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis$1,049,926
R01 · FY2018 · HL
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis$545,029
R01 · FY2018 · HL
Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency$394,284
R01 · FY2018 · HL
Role of T-bet+CD11c+ B Cells in Sarcoidosis$237,750
R21 · FY2018 · AI
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis$551,722
R01 · FY2017 · HL · contact PI
Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency$394,284
R01 · FY2017 · HL
Role of T-bet+CD11c+ B Cells in Sarcoidosis$198,125
R21 · FY2017 · AI
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis$568,960
R01 · FY2016 · HL · contact PI
Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency$393,891
R01 · FY2016 · HL
Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency$393,891
R01 · FY2015 · HL
2015 AASOG Meeting: Reducing Disparities in Sarcoidosis Through Personalized Care and Increased Detection$10,000
R13 · FY2015 · HL · contact PI